Table 1 Clinical and pathologic features of pts
Tot | Group A (BCG) | Group B (BCG + HA) | |
|---|---|---|---|
Gender | |||
M | 23 (76%) | 12 (80%) | 11 (73%) |
F | 7 (24%) | 3 (20%) | 4 (27%) |
Age | |||
Mean | 67 | 66 | 68 |
Range | 54-81 | 54-75 | 60-81 |
N° of tumors | |||
Single | 9 (30%) | 5 (33%) | 4 (27%) |
Multiple | 21 (70%) | 10 (67%) | 11 (53%) |
Tumor diameter | |||
Mean | 1,5 cm | 1,5 cm | 1,5 cm |
Range | 5 cm – 50 cm | 5 cm – 40 cm | 5 cm – 50 cm |
pT | |||
Ta | 17 (56%) | 9 (60%) | 8 (53%) |
T1 | 13 (44%) | 6 (40%) | 7 (47%) |
CIS | 8 (27%) | 3 (20%) | 5 (33%) |
WHO grade 1973 | |||
G1 | 8 (27%) | 4 (27%) | 4 (27%) |
G2 | 10 (33%) | 6 (40%) | 4 (27%) |
G3 | 12 (40%) | 5 (33%) | 7 (46%) |
EORTC recurrence score | |||
≤ 9 intermediate | 10 (33%) | 6 (40%) | 4 (27%) |
10-17 high | 20 (67%) | 9 (60%) | 11 (73%) |
EORTC progressive score | |||
≤6 intermediate | 11 (36%) | 6 (40%) | 5 (33%) |
7-23 high | 19 (64%) | 9 (60%) | 10 (67%) |